Abstract
The evidence as to the prognostic significance of perineural invasion in adenoid cystic carcinoma of the salivary glands is equivocal. Nevertheless, many head and neck surgeons and oncologists take account of histologically proven perineural invasion when planning treatment for adenoid cystic carcinoma. This review presents a digest of the data showing how neural involvement by adenoid cystic carcinoma of the salivary glands relates to local anatomy, and how this influences the extent of surgery and planning of radiotherapy.
Keywords: Adenoid cystic carcinoma, head and neck, salivary glands, prognostic factors, epithelial salivary neoplasms, World Health Organisation, nerve axon, squamous cell carcinomas, paralysis, facial nerve, prognosis, multivariate analysis, prognostic indicator, paraesthesia, deafness, diplopia, pain, gravity, metastasis, pulmonary disease can still live for a considerable time [18]. Morbidity and mor, gland, meninges, nerve, maxillary sinus, optic nerve, mylohyoid nerves, submandibular gland, parotid tumours, skull base, fluorescent dyes, surgical margin
Current Cancer Therapy Reviews
Title: Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Anatomical Influences on Oncological Management
Volume: 7 Issue: 1
Author(s): A. William Barrett and Paul M. Speight
Affiliation:
Keywords: Adenoid cystic carcinoma, head and neck, salivary glands, prognostic factors, epithelial salivary neoplasms, World Health Organisation, nerve axon, squamous cell carcinomas, paralysis, facial nerve, prognosis, multivariate analysis, prognostic indicator, paraesthesia, deafness, diplopia, pain, gravity, metastasis, pulmonary disease can still live for a considerable time [18]. Morbidity and mor, gland, meninges, nerve, maxillary sinus, optic nerve, mylohyoid nerves, submandibular gland, parotid tumours, skull base, fluorescent dyes, surgical margin
Abstract: The evidence as to the prognostic significance of perineural invasion in adenoid cystic carcinoma of the salivary glands is equivocal. Nevertheless, many head and neck surgeons and oncologists take account of histologically proven perineural invasion when planning treatment for adenoid cystic carcinoma. This review presents a digest of the data showing how neural involvement by adenoid cystic carcinoma of the salivary glands relates to local anatomy, and how this influences the extent of surgery and planning of radiotherapy.
Export Options
About this article
Cite this article as:
William Barrett A. and M. Speight Paul, Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Anatomical Influences on Oncological Management, Current Cancer Therapy Reviews 2011; 7 (1) . https://dx.doi.org/10.2174/157339411794474119
DOI https://dx.doi.org/10.2174/157339411794474119 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evolution and Pathogenesis of Oncoviruses Associated with Head and Neck Cancer: History and Current Concepts
Recent Patents on Biomarkers Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Current Signal Transduction Therapy Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents
Current Pharmaceutical Design Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies
Current Topics in Medicinal Chemistry Using Natural Compounds to Target KRAS Mutated Non-Small Cell Lung Cancer
Current Medicinal Chemistry Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Emerging Breast Cancer Biomarkers
Current Cancer Therapy Reviews The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Current Medicinal Chemistry High Order Texture-Based Analysis in Biomedical Images
Current Medical Imaging Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Methotrexate-Induced Pneumonitis: Heterogeneity of Bronchoalveolar Lavage and Differences between Cancer and Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) “Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems
Drug Delivery Letters Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach
Recent Patents on Biotechnology Vemurafenib Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Disproportionality Analysis in FAERS Database
Current Reviews in Clinical and Experimental Pharmacology Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
Current Cancer Drug Targets Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers
Current Pharmaceutical Design